Skip to main content

Xeris Biopharma Holdings, Inc.

XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867096

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 9 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Xeris Biopharma Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
3 insiders, $1.85M in total
Insiders trading
3
Net value
−$1.85M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Xeris Biopharma Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Xeris Biopharma Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
McCulloch KevinSee Remarks1,639,208Sep 1, 20268
Hecht BethSee Remarks1,127,796Sep 1, 202611
Pieper StevenSee Remarks1,356,053Sep 1, 20265
Shannon John Patrick JrSee Remarks2,898,933Aug 21, 20264
Kreher NerissaDirector33,582Jul 2, 20261
Persky MarlaDirector150,693Jun 5, 20261
Johnson JohnDirector707,276Jun 5, 20262
Kong GarhengDirector238,337Jun 5, 20261
Bormann-Kennedy Barbara-Jean AnneDirector150,693Jun 5, 20262
Halkuff DawnDirector119,193Jun 5, 20261
Brady James AloysiusDirector113,359Jun 5, 20262
Nguyen Anh TuSee Remarks395,023Feb 25, 20262
Sherman Jeffrey WDirector219,188Aug 29, 20250
Johnson Kenneth ErlandSee Remarks320,446Feb 3, 20250
Schmid John P.Director25,200IndirectAug 13, 20240
Fairley Ricki LouiseDirector135,000Jun 5, 20240
Edick Paul RSee Remarks3,788,064Jan 31, 20240
Prestrelski StevenChief Scientific Officer719,780Feb 1, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 1, 2026 (view filing)6:21 PM ETSep 1Same dayMcCulloch KevinSee RemarksSSale−15.0K$8.49−$127.3K−0.9%1.64M after10b5-1
Sep 1, 2026 (view filing)6:21 PM ETSep 1Same dayHecht BethSee RemarksSSale−16.7K$8.49−$141.4K−1.5%1.13M after10b5-1
Sep 1, 2026 (view filing)6:20 PM ETSep 1Same dayPieper StevenSee RemarksSSale−5.00K$8.50−$42.5K−0.4%1.36M after10b5-1
Aug 12, 2026 (view filing)4:44 PM ETAug 12Same dayPieper StevenSee RemarksSSale−5.00K$8.50−$42.5K−0.4%1.36M after10b5-1
Aug 4, 2026 (view filing)5:30 PM ETAug 31 dayMcCulloch KevinSee RemarksSSale−15.0K$8.02−$120.2K−0.9%1.68M after10b5-1
Aug 4, 2026 (view filing)5:16 PM ETAug 31 dayHecht BethSee RemarksSSale−16.7K$8.01−$133.6K−1.4%1.14M after10b5-1
Jul 7, 2026 (view filing)5:11 PM ETJul 6-71 dayPieper StevenSee RemarksSSale−45.0K$8.52−$383.2K−3.2%1.37M after2 lots10b5-1
Jul 2, 2026 (view filing)4:40 PM ETJul 11 dayMcCulloch KevinSee RemarksSSale−90.0K$8.03−$722.5K−5.1%1.69M after10b5-1
Jul 2, 2026 (view filing)4:38 PM ETJul 11 dayHecht BethSee RemarksSSale−16.7K$8.03−$133.9K−1.4%1.16M after10b5-1
Jun 5, 2026 (view filing)Jun 32 daysPersky MarlaDirectorSSale−15.5K$5.90−$91.5K−10.9%126.5K after10b5-1
Jun 5, 2026 (view filing)Jun 41 dayHalkuff DawnDirectorSSale−20.0K$6.09−$121.8K−17.4%95.0K after10b5-1
Jun 5, 2026 (view filing)Jun 41 dayBormann-Kennedy Barbara-Jean AnneDirectorSSale−16.0K$6.09−$97.4K−11.2%126.5K after10b5-1
Jun 5, 2026 (view filing)Jun 41 dayJohnson JohnDirectorSSale−15.0K$6.09−$91.3K−2.1%683.1K after10b5-1
Jun 2, 2026 (view filing)Jun 11 dayHecht BethSee RemarksSSale−16.7K$6.06−$101.0K−1.4%1.18M after10b5-1
May 1, 2026 (view filing)May 1Same dayHecht BethSee RemarksSSale−16.7K$6.23−$103.8K−1.4%1.19M after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysHecht BethSee RemarksSSale−16.7K$5.99−$99.8K−1.4%1.21M after10b5-1
Apr 1, 2026 (view filing)Mar 302 daysBrady James AloysiusDirectorSSale−10.8K$5.54−$60.0K−10.8%89.2K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysHecht BethSee RemarksSSale−16.7K$6.24−$104.1K−1.3%1.23M after2 lots10b5-1
Feb 2, 2026 (view filing)Feb 2Same dayHecht BethSee RemarksSSale−16.7K$7.45−$124.2K−1.3%1.24M after
Jan 9, 2026 (view filing)Jan 81 dayMcCulloch KevinSee RemarksSSale−15.0K$8.00−$120.0K−0.9%1.69M after10b5-1
Jan 6, 2026 (view filing)Jan 51 dayShannon John Patrick JrSee RemarksSSale−24.9K$7.08−$176.3K−0.9%2.71M after
Jan 5, 2026 (view filing)Jan 23 daysHecht BethSee RemarksSSale−16.7K$7.43−$123.8K−1.3%1.31M after10b5-1
Dec 19, 2025 (view filing)Dec 19Same dayJohnson JohnDirectorSSale−135.4K$7.22−$977.6K−16.2%698.1K after
Dec 15, 2025 (view filing)Dec 123 daysBormann-Kennedy Barbara-Jean AnneDirectorSSale−15.0K$7.09−$106.3K−9.5%142.5K after10b5-1
Dec 2, 2025 (view filing)Dec 11 dayHecht BethSee RemarksSSale−16.7K$7.01−$116.8K−1.2%1.32M after10b5-1
Nov 17, 2025 (view filing)Nov 134 daysShannon John Patrick JrSee RemarksSSale−23.2K$7.46−$173.4K−0.9%2.64M after
Nov 13, 2025 (view filing)Nov 112 daysHecht BethSee RemarksSSale−16.7K$7.40−$123.3K−1.2%1.34M after10b5-1
Sep 12, 2025 (view filing)Sep 111 dayPersky MarlaDirectorSSale−15.5K$7.72−$119.7K−9.8%142.0K after10b5-1
Aug 29, 2025 (view filing)Aug 281 daySherman Jeffrey WDirectorSSale−42.2K$7.92−$334.5K−16.2%219.2K after
Aug 15, 2025 (view filing)Aug 132 daysJohnson JohnDirectorSSale−107.5K$7.32−$786.9K−11.4%833.5K after
Aug 13, 2025 (view filing)Aug 121 dayHalkuff DawnDirectorSSale−42.5K$7.28−$309.4K−27.0%115.0K after
Jun 16, 2025 (view filing)Jun 133 daysMcCulloch KevinSee RemarksPPurchase+25.0K$4.38+$109.5K+1.5%1.71M after
Mar 21, 2025 (view filing)Mar 201 dayHecht BethSee RemarksSSale−40.0K$5.43−$217.2K−2.9%1.35M after
Aug 13, 2024 (view filing)Aug 121 daySchmid John P.DirectorPPurchase+4.51K$2.25+$10.2K+21.8%25.2K after
Aug 12, 2024 (view filing)Aug 93 daysSchmid John P.DirectorPPurchase+4.29K$2.37+$10.2K+26.1%20.7K after
May 10, 2024 (view filing)May 10Same daySchmid John P.DirectorPPurchase+5.40K$1.91+$10.3K+49.1%16.4K after
Mar 14, 2024 (view filing)Mar 14Same daySchmid John P.DirectorPPurchase+4.50K$2.16+$9.72K+69.2%11.0K after
Nov 29, 2023 (view filing)Nov 272 daysSherman Jeffrey WDirectorPPurchase+5.40K$1.87+$10.1KNew position5.40K after
Nov 21, 2023 (view filing)Nov 201 dayHalkuff DawnDirectorPPurchase+5.41K$1.84+$9.95KNew position5.41K after
Nov 21, 2023 (view filing)Nov 201 dayPieper StevenSee RemarksPPurchase+28.0K$1.95+$54.6K+2.4%1.18M after
Nov 17, 2023 (view filing)Nov 161 daySchmid John P.DirectorPPurchase+6.50K$1.51+$9.81KNew position6.50K after
Nov 17, 2023 (view filing)Nov 17Same dayShannon John Patrick JrSee RemarksPPurchase+30.8K$1.64+$50.5K+2.2%1.41M after
Nov 15, 2023 (view filing)Nov 141 dayPersky MarlaDirectorPPurchase+6.37K$1.58+$10.1KNew position6.37K after
Aug 9, 2023 (view filing)Aug 9Same dayEdick Paul RSee RemarksPPurchase+10.0K$2.38+$23.8K+0.4%2.29M after
Dec 14, 2022 (view filing)Dec 131 dayEdick Paul RSee RemarksPPurchase+20.0K$1.45+$29.0K+1.3%1.53M after
May 13, 2022 (view filing)May 121 dayEdick Paul RSee RemarksPPurchase+100.0K$1.40+$140.0K+7.1%1.51M after
Feb 24, 2022 (view filing)Feb 222 daysPrestrelski StevenChief Scientific OfficerSSale−11.2K$2.42−$27.2K−1.9%569.8K after
Nov 16, 2021 (view filing)Nov 151 dayEdick Paul RSee RemarksPPurchase+20.0K$2.28+$45.6K+148.9%33.4K after
Nov 12, 2021 (view filing)Nov 11-121 dayShannon John Patrick JrSee RemarksPPurchase+100.0K$2.10+$209.6K+37.9%363.8K after2 lots
Nov 12, 2021 (view filing)Nov 111 dayEdick Paul RSee RemarksPPurchase+200.0K$2.08+$416.0K+32.9%808.1K after